drugset / Trial / NCT03077620
Sleep Quality and Amyloid-Beta Kinetics
RandomizedParallel-groupSingle-blindOther
Summary
The purpose of this study is to change the concentration of amyloid-beta in human cerebrospinal fluid (CSF) by modification of sleep efficiency.
Timeline
- Start
- 2016-11
- Primary completion
- 2021-03-28
- Completion
- 2021-03-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Suvorexant | Small molecule | 10 mg | — |
| Subject | Suvorexant | Small molecule | 20 mg | — |
Indications
No indication recorded.